15.02.2013 Views

world cancer report - iarc

world cancer report - iarc

world cancer report - iarc

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

T<br />

Fig. 5.101 Nuclear magnetic resonance imaging<br />

scan of the brain of an HIV-infected patient showing<br />

a large lymphoma (T) in the basal ganglia.<br />

Fig. 5.102 Follicular non-Hodgkin lymphoma.<br />

Detection<br />

The most common presentation of non-<br />

Hodgkin lymphoma is painless swelling of<br />

the lymph nodes in the neck, armpit or<br />

groin. This may be associated with so<br />

called “B symptoms” of unexplained fever,<br />

night sweats and weight loss. Other related<br />

symptoms include fatigue, malaise,<br />

pruritus, or those related to organ involvement<br />

(e.g. indigestion caused by gastric<br />

lymphoma). Extranodal involvement is<br />

common. Diagnosis is dependent on<br />

obtaining a tissue biopsy, usually by excision<br />

of an enlarged node. Pathological<br />

review is crucial to identify the type of<br />

lymphoma.<br />

Staging practice commonly involves full<br />

blood count, biochemical screen including<br />

tests of liver function and renal function,<br />

chest X-ray, CT scan of neck, chest,<br />

abdomen and pelvis, and bone marrow<br />

biopsy. In some instances, lumbar puncture<br />

may be required to assess central<br />

nervous system involvement, which can<br />

have important therapeutic implications.<br />

Hodgkin disease usually originates in<br />

lymph nodes (often in the neck), and only<br />

rarely spreads outside primary lymphoid<br />

tissues. Diagnosis requires a tissue biopsy,<br />

ideally a whole lymph node. Many of<br />

the staging techniques employed are the<br />

same as for non-Hodgkin lymphoma, and<br />

the Ann Arbor staging system is used to<br />

provide treatment planning information<br />

and aid response assessment.<br />

Pathology and genetics<br />

Lymphomas constitute a diverse range of<br />

diseases (Table 5.10). Advances in molecular<br />

biology, genetics and immunology<br />

have meant that there have been profound<br />

changes in the classification of<br />

neoplasms of lymphoid cells over the last<br />

20 years. In the Revised European-<br />

American Lymphoma classification system,<br />

three broad categories are recognized:<br />

Hodgkin disease and T-cell and Bcell<br />

non-Hodgkin lymphomas. A WHO<br />

classification has recently been published<br />

[3]; prior to this the International Working<br />

Formulation (IWF) was the most widely<br />

used classification.<br />

Non-Hodgkin lymphomas are derived<br />

from B or T lymphocytes. In Western<br />

countries, B-cell tumours are more common<br />

(about 75% of cases), whereas T-cell<br />

tumours are less common but are generally<br />

more biologically aggressive. T-cell<br />

tumours are relatively more common in<br />

Table 5.10 Frequency of various types of non-Hodgkin lymphoma.<br />

East Asia. A follicular lymphoma is<br />

defined by the retention of the follicles<br />

within a lymph node (Fig. 5.102), whereas<br />

a diffuse lymphoma results from the infiltration<br />

of the node with effacement of the<br />

follicles by the malignant cells. The size of<br />

the malignant lymphocytes is also important.<br />

In contrast, Hodgkin disease is characterized<br />

by the presence of multinucleate,<br />

giant so-called “Reed-Sternberg” cells,<br />

which may be rare in a particular biopsy<br />

specimen and the surrounding cell proliferation.<br />

The Revised European-American<br />

Lymphoma classification [4] also covers<br />

Hodgkin disease; four histological subtypes<br />

of Hodgkin disease are recognized:<br />

nodular sclerosing, mixed cellularity, lymphocyte<br />

predominance and lymphocyte<br />

depletion.<br />

Many cytogenetic and molecular abnormalities<br />

in non-Hodgkin lymphoma, in<br />

particular Burkitt lymphoma, are caused<br />

by a translocation of the oncogene C-<br />

MYC from chromosome 8 to either the<br />

immunoglobulin heavy chain region on<br />

chromosome 14 or to one of the light<br />

chain loci on chromosomes 2 or 22 [5].<br />

Technological innovations, such as<br />

microarrays, are revolutionizing diagnosis<br />

(Fig. 5.105).<br />

Genetic abnormalities in Hodgkin disease<br />

are less frequently described, perhaps<br />

due to the paucity of malignant cells in<br />

the biopsy specimen.<br />

Diagnosis % of total cases<br />

Diffuse large B-cell lymphoma 30.6<br />

Follicular lymphoma 22.1<br />

MALT lymphoma 7.6<br />

Mature T-cell lymphomas (except ALCL) 7.6<br />

Chronic lymphocytic leukaemia/small lymphocytic 6.7<br />

lymphoma<br />

Mantle cell lymphoma 6.0<br />

Mediastinal large B-cell lymphoma 2.4<br />

Anaplastic large cell lymphoma (ALCL) 2.4<br />

Burkitt lymphoma 2.5<br />

Nodal marginal zone lymphoma 1.8<br />

Precursor T lymphoblastic 1.7<br />

Lymphoplasmacytic lymphoma 1.2<br />

Other types 7.4<br />

Lymphoma<br />

239

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!